BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37032583)

  • 1. The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's Syndrome.
    Tarn J; Evans E; Traianos E; Collins A; Stylianou M; Parikh J; Bai Y; Guan Y; Frith J; Lendrem D; Macrae V; McKinnon I; Simon BS; Blake J; Baker MR; Taylor JP; Watson S; Gallagher P; Blamire A; Newton J; Ng WF
    Neuromodulation; 2023 Apr; 26(3):681-689. PubMed ID: 37032583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue and Immune Responses in Patients With Primary Sjögren's Syndrome.
    Tarn J; Legg S; Mitchell S; Simon B; Ng WF
    Neuromodulation; 2019 Jul; 22(5):580-585. PubMed ID: 30328647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial direct current stimulation for fatigue in patients with Sjogren's syndrome: A randomized, double-blind pilot study.
    Pinto ACPN; Piva SR; Vieira AGDS; Gomes SGCN; Rocha AP; Tavares DRB; Santana MVA; Carlesso C; Andriolo A; Santos FC; Fregni F; Trevisani VFM
    Brain Stimul; 2021; 14(1):141-151. PubMed ID: 33340767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomic Nervous System Dysfunction in Primary Sjögren's Syndrome.
    Davies K; Ng WF
    Front Immunol; 2021; 12():702505. PubMed ID: 34381453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study.
    Tassorelli C; Grazzi L; de Tommaso M; Pierangeli G; Martelletti P; Rainero I; Dorlas S; Geppetti P; Ambrosini A; Sarchielli P; Liebler E; Barbanti P;
    Neurology; 2018 Jul; 91(4):e364-e373. PubMed ID: 29907608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial.
    Martelletti P; Barbanti P; Grazzi L; Pierangeli G; Rainero I; Geppetti P; Ambrosini A; Sarchielli P; Tassorelli C; Liebler E; de Tommaso M;
    J Headache Pain; 2018 Nov; 19(1):101. PubMed ID: 30382909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Sjögren's syndrome.
    Sawyer S
    Nurs Stand; 2004 Feb 18-24; 18(23):33-6. PubMed ID: 15017814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.
    Diener HC; Goadsby PJ; Ashina M; Al-Karagholi MA; Sinclair A; Mitsikostas D; Magis D; Pozo-Rosich P; Irimia Sieira P; Làinez MJ; Gaul C; Silver N; Hoffmann J; Marin J; Liebler E; Ferrari MD
    Cephalalgia; 2019 Oct; 39(12):1475-1487. PubMed ID: 31522546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of resistance training in patients with primary Sjogren's syndrome.
    Dardin LP; Garcia ABA; Minali PA; Pinto ACPN; Trevisani VFM
    Clin Rheumatol; 2022 Apr; 41(4):1145-1152. PubMed ID: 34748096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Transcutaneous Vagus Nerve Stimulation Decreases Whole Blood Culture-Derived Cytokines and Chemokines: A Randomized, Blinded, Healthy Control Pilot Trial.
    Lerman I; Hauger R; Sorkin L; Proudfoot J; Davis B; Huang A; Lam K; Simon B; Baker DG
    Neuromodulation; 2016 Apr; 19(3):283-90. PubMed ID: 26990318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial.
    Grazzi L; Tassorelli C; de Tommaso M; Pierangeli G; Martelletti P; Rainero I; Geppetti P; Ambrosini A; Sarchielli P; Liebler E; Barbanti P;
    J Headache Pain; 2018 Oct; 19(1):98. PubMed ID: 30340460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Sham-Controlled Cross-Over Study on the Short-Term Effect of Non-Invasive Cervical Vagus Nerve Stimulation on Spinal and Supraspinal Nociception in Healthy Subjects.
    Alt LK; Wach K; Liebler EJ; Straube A; Ruscheweyh R
    Headache; 2020 Sep; 60(8):1616-1631. PubMed ID: 32592516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.
    Silberstein SD; Mechtler LL; Kudrow DB; Calhoun AH; McClure C; Saper JR; Liebler EJ; Rubenstein Engel E; Tepper SJ;
    Headache; 2016 Sep; 56(8):1317-32. PubMed ID: 27593728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical fatigue characterises patient experience of primary Sjögren's syndrome.
    Arends S; Meiners PM; Moerman RV; Kroese FG; Brouwer E; Spijkervet FK; Vissink A; Bootsma H
    Clin Exp Rheumatol; 2017; 35(2):255-261. PubMed ID: 28032845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vagal nerve stimulation as a possible non-invasive treatment for chronic widespread pain in Gulf Veterans with Gulf War Illness.
    Natelson BH; Stegner AJ; Lange G; Khan S; Blate M; Sotolongo A; DeLuca M; Van Doren WW; Helmer DA
    Life Sci; 2021 Oct; 282():119805. PubMed ID: 34237313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue in primary Sjögren's syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study.
    Davies K; Mirza K; Tarn J; Howard-Tripp N; Bowman SJ; Lendrem D; ; Ng WF
    Rheumatol Int; 2019 Nov; 39(11):1867-1873. PubMed ID: 31250166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial.
    Aranow C; Atish-Fregoso Y; Lesser M; Mackay M; Anderson E; Chavan S; Zanos TP; Datta-Chaudhuri T; Bouton C; Tracey KJ; Diamond B
    Ann Rheum Dis; 2021 Feb; 80(2):203-208. PubMed ID: 33144299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acupuncture for Primary Sjögren Syndrome (pSS) on symptomatic improvements: study protocol for a randomized controlled trial.
    Jiang Q; Zhang H; Pang R; Chen J; Liu Z; Zhou X
    BMC Complement Altern Med; 2017 Jan; 17(1):61. PubMed ID: 28103850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue in primary Sjögren's syndrome is associated with an objective decline in physical performance, pain and depression.
    Prak RF; Arends S; Verstappen GM; van Zuiden G; Kroese FGM; Bootsma H; Zijdewind I
    Clin Exp Rheumatol; 2022 Dec; 40(12):2318-2328. PubMed ID: 36226629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 inhibition and fatigue in primary Sjögren's syndrome--a double blind, randomised clinical trial.
    Norheim KB; Harboe E; Gøransson LG; Omdal R
    PLoS One; 2012; 7(1):e30123. PubMed ID: 22253903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.